Nektar Therapeutics (NKTR)
68.43
-1.33
(-1.91%)
USD |
NASDAQ |
Sep 14, 16:00
68.68
+0.25
(+0.37%)
After-Hours: 17:01
Nektar Therapeutics Price to Book Value : 2.586 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.636 |
| September 10, 2026 | 2.670 |
| September 09, 2026 | 2.771 |
| September 08, 2026 | 2.851 |
| September 04, 2026 | 2.804 |
| September 03, 2026 | 2.886 |
| September 02, 2026 | 2.749 |
| September 01, 2026 | 2.712 |
| August 31, 2026 | 2.698 |
| August 28, 2026 | 2.741 |
| August 27, 2026 | 2.817 |
| August 26, 2026 | 2.788 |
| August 25, 2026 | 2.833 |
| August 24, 2026 | 2.785 |
| August 21, 2026 | 2.797 |
| August 20, 2026 | 2.817 |
| August 19, 2026 | 2.875 |
| August 18, 2026 | 2.783 |
| August 17, 2026 | 2.746 |
| August 14, 2026 | 2.760 |
| August 13, 2026 | 2.869 |
| August 12, 2026 | 2.873 |
| August 11, 2026 | 2.853 |
| August 10, 2026 | 2.829 |
| August 07, 2026 | 2.890 |
| Date | Value |
|---|---|
| August 06, 2026 | 2.776 |
| August 05, 2026 | 2.762 |
| August 04, 2026 | 2.750 |
| August 03, 2026 | 2.668 |
| July 31, 2026 | 2.671 |
| July 30, 2026 | 2.700 |
| July 29, 2026 | 2.671 |
| July 28, 2026 | 2.674 |
| July 27, 2026 | 2.696 |
| July 24, 2026 | 2.673 |
| July 23, 2026 | 2.621 |
| July 22, 2026 | 2.620 |
| July 21, 2026 | 2.595 |
| July 20, 2026 | 2.450 |
| July 17, 2026 | 2.580 |
| July 16, 2026 | 2.534 |
| July 15, 2026 | 2.581 |
| July 14, 2026 | 2.538 |
| July 13, 2026 | 2.582 |
| July 10, 2026 | 2.659 |
| July 09, 2026 | 2.756 |
| July 08, 2026 | 2.717 |
| July 07, 2026 | 2.830 |
| July 06, 2026 | 2.764 |
| July 02, 2026 | 2.685 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Elite Pharmaceuticals, Inc. | 2.702 |
| Daré Bioscience, Inc. | -- |
| Aclaris Therapeutics, Inc. | 6.341 |
| Eton Pharmaceuticals, Inc. | 34.95 |
| Journey Medical Corp. | 6.373 |
Price to Book Value Related Metrics
| PS Ratio | 30.41 |
| PEG Ratio | -0.0762 |
| Price | 68.43 |
| Earnings Yield | -9.79% |
| Market Cap | 2.335B |
| PEGY Ratio | -0.0762 |